{"nct_id":"NCT03325881","title":"Efficacy and Safety of SHP465 at 6.25 mg in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-12 Years","status":"COMPLETED","status_verified_date":"2021-05","start_date":"2017-12-09","start_date_type":"ACTUAL","primary_completion_date":"2018-06-07","primary_completion_date_type":"ACTUAL","completion_date":"2018-06-07","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["TAK"]}